echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The cost of the new crown vaccine is covered by health insurance and finance

    The cost of the new crown vaccine is covered by health insurance and finance

    • Last Update: 2021-01-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    , the situation of epidemic prevention and control is still serious and complex. In particular, the Spring Festival is coming, the number of overseas returning personnel, large mobility of domestic personnel, gathering activities, especially indoor activities, will increase the risk of spread of the epidemic.
    On the recent outbreak prevention and control and vaccination of social concerns,
    joint prevention and control mechanism held a press conference on January 9, the deputy director of the National Health and Safety Commission,
    joint prevention and control mechanism research team vaccine research and development team leader Zeng Yixin, deputy director of the National Health Insurance Bureau Li Tao, the national health care commission CDC head Cui Gang,
    joint prevention and control mechanism research and development team leader Zheng Zhongwei, China's CDCfor the collection of vaccination fees in individual places, Mr Zeng said that we had sent a message on behalf of the integrated unit of the
    Joint Prevention and Control Mechanism calling for immediate rectification. At present, it seems that all places have done a good job in implementing the free vaccination policy.
    he pointed out that all places are required to refer to the nucleic acid testing "should be tested" model, by all levels of government to organize and arrange cost protection, to promote the vaccination of the new crown vaccine, individuals do not bear the cost of the vaccine and vaccination costs.
    Li Tao said that after the new crown vaccine conditional listing, free vaccination is the residents informed voluntary premise, enterprises at the agreed price of the cost of providing vaccines, plus vaccination services and other full costs, will be jointly borne by the health insurance fund and finance, residents do not bear.
    "We mainly through the use of the health insurance fund rolling balance and financial funds to jointly bear the cost of the new crown vaccine and vaccination, does not affect the current health insurance fund income and expenditure, will not affect the treatment of medical treatment. Li Tao said that the relevant departments are currently working with the relevant departments to develop a vaccine conditional post-market vaccination cost protection of the detailed operation plan.is the most powerful weapon to control the pandemic of infectious diseases. According to Zeng Yixin, since December 15, 2020, China has carried out new crown vaccination work for key population groups. As of today, nearly 7.5 million doses have been given, plus more than 1.6 million doses previously given to high-risk populations, resulting in a cumulative total of more than 9 million doses of vaccination.
    Zeng Yixin said that with the new coronavirus vaccine conditional on the market, especially with the production and supply of security capacity gradually improved, will be a comprehensive and orderly promotion of high-risk groups, high-risk groups and the general population vaccination work, and the implementation of free vaccination for all. Eligible people can achieve "all-in-one", thus building an immune barrier to block the spread of the new coronavirus.
    the safety and effectiveness of the new crown vaccine has attracted much attention. In this regard, Wang Huaqing introduced, according to the monitoring results, now reported suspected adverse reactions, 80% are general adverse reactions, of which six out of 100,000 are abnormal reactions, most of them are allergic rashes, serious adverse reactions are about one in a million.
    Wang Huaqing, said that compared with historical data, there is no abnormal situation. It is also known that adverse reactions to vaccines are characteristic. At present, foreign countries are also inoculated with the new crown vaccine, there are adverse reactions and occasional reports of serious adverse reactions, which is a normal phenomenon in the vaccination process.
    Wang Huaqing stressed that before vaccination, vaccination agencies should inform the characteristics of the vaccine and adverse reactions to the vaccine, after the informed consent of the subject to be vaccinated. In addition, when the subject to be vaccinated, be sure to inform the vaccination doctor of their health status truthfully, the vaccination doctor will make a decision whether or not to be vaccinated.
    he pointed out that after vaccination, stay on site for 30 minutes. In the event of a severe allergic reaction, timely treatment can be provided at the scene. If after 30 minutes of observation, suspect that they have any problems or physical discomfort, it is also recommended to go to the hospital in a timely manner.the variation of the new coronavirus has been a hot issue of great concern to the society. In this regard, Zeng Yixin said, China from the beginning set up a special task force to study and monitor the new coronavirus mutation. Recently in the UK, there has been a new mutation in the virus, the S protein 501 amino acid mutation, which happens to be in a critical position, is the virus and human cells in the binding of the key site.
    s particularly concerned about this situation, " said Mr. Zeng. The Chinese
    Institute of Experimental Animals and the Institute of Viruses of Zhongshan University have studied the strain.
    , he said, researchers have compared the virus that appeared in China between January and June with this time in the UK. It is clear from the study that early viral strains in the country and mutant strains in the UK do not affect the protection of vaccines.
    stressed that the mutation of the virus is an ongoing process. At present, it seems that the new coronavirus mutation rate is still within the acceptable range, the mutation rate is not particularly fast. However, we should pay close attention to, continue to closely monitor the virus mutation, in case the mutation accumulates to a certain extent, affecting the protection of the vaccine, we also need to prepare in advance, to carry out broad-spectrum new crown vaccine or mutated new crown vaccine research, in order to effectively respond to possible problems.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.